Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance

Abstract

Tacrolimus therapy appears to be associated with both short- and long-term benefits, and may represent a therapeutic option in Crohn's disease when conventional therapies fail. This study encourages its use in controlled trials.